Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia

Abdurehman Eshete Mohammed, Tilahun Yemane Shenkute, Waqtola Cheneke Gebisa Department of Medical Laboratory Sciences and Pathology, College of Health Sciences, Jimma University, Jimma, Ethiopia Background: Globally, diabetes is rising dramatically causing high health burden in low- and middle-inco...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohammed AE, Shenkute TY, Gebisa WC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/5498e4a5d5d749e5918ec9448c9bbbac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5498e4a5d5d749e5918ec9448c9bbbac
record_format dspace
spelling oai:doaj.org-article:5498e4a5d5d749e5918ec9448c9bbbac2021-12-02T02:44:18ZDiabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia1178-7007https://doaj.org/article/5498e4a5d5d749e5918ec9448c9bbbac2015-04-01T00:00:00Zhttp://www.dovepress.com/diabetes-mellitus-and-risk-factors-in-human-immunodeficiency-virus-inf-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Abdurehman Eshete Mohammed, Tilahun Yemane Shenkute, Waqtola Cheneke Gebisa Department of Medical Laboratory Sciences and Pathology, College of Health Sciences, Jimma University, Jimma, Ethiopia Background: Globally, diabetes is rising dramatically causing high health burden in low- and middle-income countries. It is estimated that about 382 million people had diabetes in 2013. In 2013, diabetes caused 5.1 million deaths globally. Almost 80% of diabetes deaths occur in low- and middle-income countries. Purpose: To assess the magnitude of diabetes mellitus (DM) and associated risk factors in human immunodeficiency virus (HIV)-infected individuals. Methods: An institution-based cross-sectional study was conducted from April to May 2014 at Jimma University Specialized Hospital. Convenient sampling technique was implemented. Sociodemographic and anthropometric data were collected by senior clinical nurses. Venous blood was collected from each study participant. Serum glucose and lipid profile of the study participants was measured using HumaStar 80 spectrophotometer. Data were analyzed using SPSS version 20. Bivariate and multivariate logistic regressions were utilized. Results: A total of 393 HIV-infected individuals of age ranging from 21 years to 75 years had enrolled in this study. The overall prevalence of DM in this study was 6.4% (n=25). Two hundred and ninety-one (74%) and 77 (19.6%) of the study participants had normal (70–110 mg/dL) and impaired (111–125 mg/dL) fasting blood glucose values, respectively. After adjusting for the other variables, age (adjusted odds ratio [AOR] =4.812, 95% confidence interval [CI]: 1.668–13.881, P=0.004), duration of highly active antiretroviral therapy (HAART) (AOR =26.928, 95% CI: 3.722–194.822, P=0.001), hypertension (AOR =4.779, 95% CI: 1.646–13.874, P=0.004), and low-density lipoprotein cholesterol (AOR =5.669, 95% CI: 1.849–17.382, P=0.004) were significantly associated with DM. Conclusion: HAART may have an impact on the cause of diabetes. Hence, HIV-infected individuals should be screened for diabetes, both before and after initiation of HAART. Keywords: diabetes mellitus, human immunodeficiency virus, Jimma, Ethiopia Mohammed AEShenkute TYGebisa WCDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2015, Iss default, Pp 197-206 (2015)
institution DOAJ
collection DOAJ
language EN
topic Specialties of internal medicine
RC581-951
spellingShingle Specialties of internal medicine
RC581-951
Mohammed AE
Shenkute TY
Gebisa WC
Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
description Abdurehman Eshete Mohammed, Tilahun Yemane Shenkute, Waqtola Cheneke Gebisa Department of Medical Laboratory Sciences and Pathology, College of Health Sciences, Jimma University, Jimma, Ethiopia Background: Globally, diabetes is rising dramatically causing high health burden in low- and middle-income countries. It is estimated that about 382 million people had diabetes in 2013. In 2013, diabetes caused 5.1 million deaths globally. Almost 80% of diabetes deaths occur in low- and middle-income countries. Purpose: To assess the magnitude of diabetes mellitus (DM) and associated risk factors in human immunodeficiency virus (HIV)-infected individuals. Methods: An institution-based cross-sectional study was conducted from April to May 2014 at Jimma University Specialized Hospital. Convenient sampling technique was implemented. Sociodemographic and anthropometric data were collected by senior clinical nurses. Venous blood was collected from each study participant. Serum glucose and lipid profile of the study participants was measured using HumaStar 80 spectrophotometer. Data were analyzed using SPSS version 20. Bivariate and multivariate logistic regressions were utilized. Results: A total of 393 HIV-infected individuals of age ranging from 21 years to 75 years had enrolled in this study. The overall prevalence of DM in this study was 6.4% (n=25). Two hundred and ninety-one (74%) and 77 (19.6%) of the study participants had normal (70–110 mg/dL) and impaired (111–125 mg/dL) fasting blood glucose values, respectively. After adjusting for the other variables, age (adjusted odds ratio [AOR] =4.812, 95% confidence interval [CI]: 1.668–13.881, P=0.004), duration of highly active antiretroviral therapy (HAART) (AOR =26.928, 95% CI: 3.722–194.822, P=0.001), hypertension (AOR =4.779, 95% CI: 1.646–13.874, P=0.004), and low-density lipoprotein cholesterol (AOR =5.669, 95% CI: 1.849–17.382, P=0.004) were significantly associated with DM. Conclusion: HAART may have an impact on the cause of diabetes. Hence, HIV-infected individuals should be screened for diabetes, both before and after initiation of HAART. Keywords: diabetes mellitus, human immunodeficiency virus, Jimma, Ethiopia 
format article
author Mohammed AE
Shenkute TY
Gebisa WC
author_facet Mohammed AE
Shenkute TY
Gebisa WC
author_sort Mohammed AE
title Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
title_short Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
title_full Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
title_fullStr Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
title_full_unstemmed Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
title_sort diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at jimma university specialized hospital, southwest ethiopia
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/5498e4a5d5d749e5918ec9448c9bbbac
work_keys_str_mv AT mohammedae diabetesmellitusandriskfactorsinhumanimmunodeficiencyvirusinfectedindividualsatjimmauniversityspecializedhospitalsouthwestethiopia
AT shenkutety diabetesmellitusandriskfactorsinhumanimmunodeficiencyvirusinfectedindividualsatjimmauniversityspecializedhospitalsouthwestethiopia
AT gebisawc diabetesmellitusandriskfactorsinhumanimmunodeficiencyvirusinfectedindividualsatjimmauniversityspecializedhospitalsouthwestethiopia
_version_ 1718402160873439232